Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 2026-09-11 pm EDT
|
5-day change | 1st Jan Change | ||
| 14.07 USD | -1.75% |
|
+1.66% | -10.27% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -9.36x | - | -0.04x | - | - | - | - | 1.2B | ||
| 31.04x | 4.15x | 1.16x | 5.6x | 16.76x | 23.45x | 1.05% | 45.48B | ||
| -20.85x | 21.54x | -0.32x | 240.83x | -22.36x | -21.1x | -.--% | 43.69B | ||
| 33.71x | 6.16x | -35.22x | 3.27x | 14.1x | 21.31x | -.--% | 43.09B | ||
| 45.39x | 7.68x | 0.22x | 5.23x | 28.64x | 32.96x | -.--% | 39.4B | ||
| 27.03x | 2.19x | 0.56x | 8.15x | 20.66x | 24.53x | 0.42% | 31.91B | ||
| 33.41x | 23.97x | 2.21x | 5.47x | 24.85x | 26x | -.--% | 16.4B | ||
| 23.57x | 2.62x | 0.68x | 2.06x | 8.94x | 13.85x | 1.13% | 14.24B | ||
| 74.44x | 4.41x | -0.33x | 3.94x | 15.27x | 18.75x | -.--% | 13.28B | ||
| 28.74x | 1.36x | 0.28x | 1.89x | 11.62x | 13.23x | -.--% | 13.05B | ||
| 52.2x | 4.55x | 2.73x | 8.66x | 24.58x | 29.32x | 0.44% | 11.31B | ||
| -42.37x | 21.24x | 34.44x | 7.06x | 172.31x | -1563.24x | -.--% | 10.65B | ||
| 37.13x | 4.27x | 2.39x | 4.39x | 18.79x | 30.21x | 0.6% | 10.13B | ||
| -28.56x | 8.41x | 1.07x | 110.17x | -28.99x | -47.94x | -.--% | 10.25B | ||
| -29.69x | 8.63x | -6.01x | 78.41x | -19.77x | -19.17x | -.--% | 9.56B | ||
| -24.09x | 8.32x | -7.89x | 10026.59x | -19.8x | -19.5x | -.--% | 9.34B | ||
| 31.86x | - | -0.1x | 16.69x | 30.46x | 29.75x | -.--% | 9.59B | ||
| -14.92x | 627.58x | -0.28x | 9.76x | -15.66x | -15.11x | -.--% | 9.01B | ||
| -344.99x | 2.26x | 3.63x | 10.15x | 60.28x | 78.87x | -.--% | 9.02B | ||
| Average | -5.07x | 44.67x | -0.04x | 586.02x | 18.93x | -74.66x | 0.2% | 18.45B | |
| Weighted average by Cap. | 10.30x | 25.06x | -3.07x | 308.18x | 15.45x | -33.81x | 0.25% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















